A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
BeOne Medicines
BeOne Medicines
NiKang Therapeutics, Inc.
AstraZeneca
National Institutes of Health Clinical Center (CC)
Seagen Inc.
AstraZeneca
Kivu Bioscience Inc.
Astellas Pharma Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Exscientia AI Limited
AstraZeneca
Sotio Biotech Inc.
National Institutes of Health Clinical Center (CC)
Radiopharm Theranostics, Ltd
National Cancer Institute (NCI)
PMV Pharmaceuticals, Inc
NeoImmuneTech
Neonc Technologies, Inc.
Tasca Therapeutics
MacroGenics
MacroGenics
SystImmune Inc.
SN BioScience
ImmunityBio, Inc.
Hoffmann-La Roche
VM Oncology, LLC
GV20 Therapeutics
DualityBio Inc.
Incyte Corporation
Janux Therapeutics
NiKang Therapeutics, Inc.
Novelty Nobility, Inc.
University of Colorado, Denver
Merck Sharp & Dohme LLC
Tianjin First Central Hospital
Pfizer
Hoffmann-La Roche
Incyte Corporation
A2 Biotherapeutics Inc.
University of Virginia
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Marengo Therapeutics, Inc.
Shanghai Public Health Clinical Center
TransThera Sciences (Nanjing), Inc.
NRG Oncology
OncoC4, Inc.
Hutchmed